NCT05789992

Brief Summary

The aim of this study is to verify the accuracy of eMAC compared to Bispectral Index (BIS) for depth and nociceptive stimulation monitoring of anesthesia during general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 29, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

April 3, 2023

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 29, 2023

Completed
Last Updated

June 15, 2023

Status Verified

June 1, 2023

Enrollment Period

26 days

First QC Date

March 2, 2023

Last Update Submit

June 13, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prediction probability of eMAC

    Prediction probability is an index(range:0-1) to describe the concordance between continuous measures and discrete scores. Prediction probability bettween eMAC and the lable of response was calculated.

    1 year

Secondary Outcomes (1)

  • Prediction probability of BIS

    1 year

Study Arms (4)

Group 1 BIS under tetanic electrical stimulation

ACTIVE COMPARATOR

During tetanic electrical stimulation, and with propofol(random:3-5ug/ml) and remifentanil(random:0-3ng/ml), the response (body movement or hemodynamic change) was observed, and recorded it's BIS.

Drug: PropofolDrug: Low RemifentanilProcedure: tetanic electrical stimulation

Group 2 eMAC under tetanic electrical stimulation

ACTIVE COMPARATOR

During tetanic electrical stimulation or intubation, and with propofol(random:3-5ug/ml) and remifentanil(random:0-3ng/ml), the response (body movement or hemodynamic change) was observed, and recorded it's eMAC.

Drug: PropofolDrug: Low RemifentanilProcedure: tetanic electrical stimulation

Group 3 BIS under intubation

ACTIVE COMPARATOR

During intubation, and with propofol(random:3-5ug/ml) and remifentanil(random:3-5ng/ml), the response (body movement or hemodynamic change) was observed, and recorded it's BIS.

Drug: PropofolDrug: Heigh RemifentanilProcedure: Intubation

Group 4 eMAC under intubation

ACTIVE COMPARATOR

During intubation, and with propofol(random:3-5ug/ml) and remifentanil(random:3-5ng/ml), the response (body movement or hemodynamic change) was observed, and recorded it's eMAC.

Drug: PropofolDrug: Heigh RemifentanilProcedure: Intubation

Interventions

Propofol (Random:3-5ug/ml)

Also known as: Propofol for tetanic electrical stimulation and intubation
Group 1 BIS under tetanic electrical stimulationGroup 2 eMAC under tetanic electrical stimulationGroup 3 BIS under intubationGroup 4 eMAC under intubation

Remifentanil (Random:0-3ug/ml)

Also known as: Remifentanil for tetanic electrical stimulation
Group 1 BIS under tetanic electrical stimulationGroup 2 eMAC under tetanic electrical stimulation

Remifentanil (Random:3-5ug/ml)

Also known as: Remifentanil for intubation
Group 3 BIS under intubationGroup 4 eMAC under intubation
IntubationPROCEDURE

Endotracheal intubation before surgery

Group 3 BIS under intubationGroup 4 eMAC under intubation

tetanic electrical stimulation before surgery

Group 1 BIS under tetanic electrical stimulationGroup 2 eMAC under tetanic electrical stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing elective surgery under general anesthesia;
  • Patients with ASA rating I\~III;
  • The age of the patient is more than 18 years old;
  • The informed consent has been signed;

You may not qualify if:

  • Patients who are participating in other trials;
  • Patients with cognitive impairment, mental illness or taking psychotropic drugs within three months;
  • Patients with a history of stroke;
  • Patients with a history of alcoholism (long-term drinking more than 5 years, daily white wine consumption ≥ 50ml);
  • Pregnant women;
  • Patients with BMI\>30;
  • Patients and family members who are unwilling to participate after understanding the research content;
  • According to the evaluation of the researcher, the actual condition is not suitable for the patients participating in this trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xijing Hospital

Xi'an, Shaanxi, China

Location

Related Publications (3)

  • Luginbuhl M, Schumacher PM, Vuilleumier P, Vereecke H, Heyse B, Bouillon TW, Struys MM. Noxious stimulation response index: a novel anesthetic state index based on hypnotic-opioid interaction. Anesthesiology. 2010 Apr;112(4):872-80. doi: 10.1097/ALN.0b013e3181d40368.

    PMID: 20216387BACKGROUND
  • Gruenewald M, Ilies C, Herz J, Schoenherr T, Fudickar A, Hocker J, Bein B. Influence of nociceptive stimulation on analgesia nociception index (ANI) during propofol-remifentanil anaesthesia. Br J Anaesth. 2013 Jun;110(6):1024-30. doi: 10.1093/bja/aet019. Epub 2013 Mar 6.

    PMID: 23471754BACKGROUND
  • Schumacher PM, Dossche J, Mortier EP, Luginbuehl M, Bouillon TW, Struys MM. Response surface modeling of the interaction between propofol and sevoflurane. Anesthesiology. 2009 Oct;111(4):790-804. doi: 10.1097/ALN.0b013e3181b799ef.

    PMID: 19741484BACKGROUND

Related Links

MeSH Terms

Interventions

PropofolIntubationRemifentanil

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsTherapeuticsInvestigative TechniquesPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Haopeng Zhang, Dr

    Xijing Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

March 2, 2023

First Posted

March 29, 2023

Study Start

April 3, 2023

Primary Completion

April 29, 2023

Study Completion

April 29, 2023

Last Updated

June 15, 2023

Record last verified: 2023-06

Locations